title: The influence of labetalol on arterial blood gas data, pulmonary haemodynamics and pulmonary shunting.
abstract: The arterial oxygen and carbon dioxide tensions, pulmonary and systemic haemodynamics and pulmonary shunting and mechanics were measured during the first 30 min after intravenous labetalol administration. Thirty patients, recovering in the intensive care unit after neurosurgical interventions were randomly divided in 2 groups of 15 patients, receiving either labetalol or placebo. In the labetalol treated group the arterial oxygen tension decreased from 553.6 +/- 16.8 to 529.3 +/- 19.8 mmHg 5 min after the injection of labetalol. A concomitant increase in arterial carbon dioxide tension from 40.1 +/- 1.1 to 45.5 +/- 1.3 mmHg was noticed. Pulmonary vascular resistance decreased from 159.6 +/- 14.7 to 116.7 +/- 11.7 dynes.sec.cm-5 and pulmonary shunting increased from 4.8% +/- 1.4% to 8.1% +/- 2.4% 5 min following injection. All these changes were statistically significant for p less than 0.01. After 30 min all values had returned to their initial level. No changes were registered in the control group. As airway resistance appeared not to be affected by the labetalol administration it may be concluded that the observed changes in blood gas data are most likely due to a transient decrease of the pulmonary vascular resistance with a concomitant increase in pulmonary shunting.
authors.affiliation: Department of Anaesthesiology and Intensive Care, University Hospital Antwerp, Edegen, Belgium.
authors.forename: S G
authors.initials: SG
authors.lastname: De Hert
authors.forename: L G
authors.initials: LG
authors.lastname: Heytens
authors.forename: R G
authors.initials: RG
authors.lastname: De Jongh
authors.forename: M P
authors.initials: MP
authors.lastname: Vercauteren
authors.forename: E A
authors.initials: EA
authors.lastname: Boeckx
authors.forename: H F
authors.initials: HF
authors.lastname: Adriaensen
mesh_terms: D000328:Adult; D001784:Blood Gas Analysis; D006259:Craniocerebral Trauma / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007741:Labetalol / Q000494:pharmacology* / Q000627:therapeutic use; D008170:Lung Compliance / Q000187:drug effects; D008875:Middle Aged; D011652:Pulmonary Circulation / Q000187:drug effects*; D011669:Pulmonary Wedge Pressure / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects
chemical_list: D007741:Labetalol